Sleep apnea-hypopnea syndrome and stroke;Síndrome de apnea hipopnea del sueño e ictus

Anales del Sistema Sanitario de Navarra

Volumn 30, Issue SUPPL. 1, 2007, Pages 97-106

  Muñoz Arrondo, Roberto ^a,b   Ramos, C ^a  

^a Universidad Pública de Navarra   (Spain)

^b NONE

Author keywords

Apnea hypopnea syndrome; Stroke; Vascular risk factor

Indexed keywords

ANAMNESIS; ARTERIAL PRESSURE; BRAIN ISCHEMIA; DISEASE ASSOCIATION; HEART ARRHYTHMIA; HEMODYNAMICS; HUMAN; POSITIVE END EXPIRATORY PRESSURE; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; STROKE;

EID: 34248354260     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. MEDRANO MJ, LÓPEZ G, BARRADO MJ, POLLÁN M, ALMAZÁN J. Effect of age, birth cohort and period of death on cerebrovascular mortality in Spain, 1952-1991. Stroke 1997; 28: 40-44.
2. HACHINSKI V. Cholesterol as a risk factor for stroke. Arch Neurol 1999; 56: 1524.
3. DIAZ J, SEMPERE A. Cerebral ischemia, new risk factors. Cerebrovascular Diseases 2004;17 (Suppl 1): 43-50.
4. CASADO I, MUÑOZ R. Apnea del sueño e ictus: nuevas evidencias, nuevos retos. Neurologia 2005; 6: 273-275.
5. YOUNG T, PALTA M, DEMPSEY J, SKATRUD J, WEBER S, BADR S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235.
6. The Report of an American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep.1999; 22: 667-689.
7. YOUNG T, PEPPARD PE, GOTTLIEB DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217-1239.
8. LINDBERG E, GISLASON T. Epidemiology of sleep-related obstructive breathing. Sleep Med Rev 2000; 4: 411-433.
9. DURÁN J, ESNAOLA S, RUBIO R, IZTUETA A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 years. Am J Respir Crit Care Med 2001; 163: 1-5.
10. MULLER JE, STONE PH, TURI ZG, RUTHERFORD JD, CZEISLER C, PARKER C et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313: 1315-1322.
11. ELLIOTT WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke 1998; 29: 992-996.
12. PARTINEN M, PALOMAKI H. Snoring and cerebral infarction. Lancet 1985; 2: 1325-1326.
13. KOSKENVUO M, KAPRIO J, TELAKIVI T, PARTINEN M, HEIKKILA K, SARNA S. Snoring as a risk factor for ischaemic heart disease and stroke in men. BMJ 1987; 294: 16-19.
14. SPRIGGS D, FRENCH J, MURDY J, CURLESS R, BATES D, JAMES O. Snoring increases the risk of stroke and adversely affects prognosis. Q J Med 1992; 83: 555-562.
15. PALOMAKI H. Snoring and the risk of ischemic brain infarction. Stroke 1991; 22: 1021-1025.
16. JENNUM P, SCHULTZ-LARSEN K, DAVIDSEN M, CHRISTENSEN NJ. Snoring and risk of stroke and ischaemic heart disease in a 70 year old population: a 6-year follow-up study. Int J Epidemiol 1994; 23: 1159-1164.
17. NEAU J, MEURICE J, PAQUEREAU J, CHAVAGNAT J, INGRAND P, GIL R. Habitual snoring as a risk factor for brain infarction. Acta Neurol Scand 1995; 92: 63-68.
18. HU F, WILLET W, MANSON J, COLDITZ GA, RIMM EB, SPEIZER FE et al. Snoring and the risk of cardiovascular disease in women. J Am Coll Cardiol 2000; 35: 308-313.
19. SHAHAR E, WHITNEY CW, REDLINE S, LEE ET, NEWMAN AB, JAVIER NIETO F et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Resp Crit Care Med 2001; 163: 19-25.
20. MARÍN JM, CARRIZO S, VICENTE E, AGUSTIN AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053.
21. YAGGI KH, CONCATO J, KERNAN W, LICHTMAN JH, BRASS LM, MOHSENIN V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005; 353: 2034-2041.
22. ARZT M, YOUNG T, FINN L, SKATRUD JB, BRADLEY TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172: 1447-1451.
23. MUÑOZ R, DURAN-CANTOLLA J, MARTÍNEZ-VILA E, GALLEGO-CULLERE J, RUBIO R, AIZPURU F et al. Severe Sleep Apnea and Risk of Ischemic Stroke in the Elderly. Stroke 2006; 37: 2317-2321.
24. FISCHER AQ, CHAUDHARY BA, TAORMINA MA, AKHTAR B. Intracranial hemodynamics in sleep apnea. Chest 1992; 102: 1402-1406.
25. NETZER N, WERNER P, JOCHUMS I, LEHMANN M, STROHL K. Blood flow of the middle cerebral artery with sleep-disordered breathing: correlation with obstructive hypopneas. Stroke 1998; 29: 87-93.
26. DIOMEDI M, PLACIDI F, CUPINI LM, BERNARDI G, SILVESTRINI M. Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment. Neurology 1998; 51: 1051-1056.
27. PLACIDI F, DIOMEDI M, CUPINI LM, BERNARDI G, SILVESTRINI M. Impairment of daytime cerebrovascular reactivity in patients with obstructive sleep apnoea syndrome. J Sleep Res 1998; 7: 288-292.
28. LUGARESI E, CIRIGNOTTA F, COCCAGNA G, PIANA C. Some epidemiologic data on snoring and cardiocirculatory disturbances. Sleep 1980; 3: 221-224.
29. NIETO FJ, YOUNG TB, LIND BK, SAHAR E, SAMET JM, REDLINE S et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study JAMA 2000; 283: 1829-1836.
30. PEPPARD P, YOUNG T, PALTA M, SKATRUD J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384.
31. FLETCHER EC, BAO G. The effect of recurrent episodic eucapnic and hypocapnic hypoxia on systemic blood pressure in hypertension prone rats. J Appl Physiol 1996; 81: 2088-2094.
32. BAO G, METREVIELI N, LI R, TAYLOR A, FLETCHER EC. Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol 1997; 83: 95-101.
33. ROSTAGNO C, TADDEI T, PALADINI B, MODESTI PA, UTARI P, BERTINI G et al. The onset of symptomatic atrial fibrillation and paroxysmal supraventricular tachycardia is characterized by different circadian rhythms. Am J Cardiol 1993; 71: 453-455.
34. YAMASHITA T, MURAKAWA Y, HAYAMI N, SEZAKI K, INOUE M, FUKUI E et al. Circadian variation of paroxysmal atrial fibrillation. Circulation 1997; 96: 1537-1541.
35. MOOE T, GULLSBY S, RABBEN T, ERIKSSON P. Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery. Coron Artery Dis. 1996; 7: 475-478.
36. JAVAHERI S, PARKER T, LIMING J, CORBET WS, NISHIYAMA H, WEXLER L et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation 1998; 97: 2154-2159.
37. KANAGALA R, MURALI NS, FRIEDMAN PA, AMMASH NM. GERSH BJ, BALLMAN KY et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003; 107: 2589-2594.
38. CHIN K, KITA H, NOGUCHI T, OTSUKA N, TSUBOI T, NAKAMURA T et al. Improvement of factor VII clotting activity following long-term NCPAP treatment in obstructive sleep apnoea syndrome. QJM 1998; 91: 627-633.
39. CHIN K, OHI M, KITA H, NOGUCHI T, OTSUKA N, TSUBOI T et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996; 153: 1972-1976.
40. WESSENDORF T, THILMANN A, WANG Y, SCHREIBER A, KONIETZKO N, TESCHLER H. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 2000; 162: 2039-2042.
41. TOFFLER G, BREZINSKI D, SHAFER A, CZEISLER CA, RUTHERFORD JD, WILLICH SN et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987; 316: 1514-1518.
42. BOKINSKY G, MILLER M, AULT K, HUSBAND P, MITCHELL M. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation. Chest 1995; 108: 625-630.
43. LAVIE L. Obstructive sleep apnoea syndrome- an oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51.
44. LAVIE L, PERELMAN A, LAVIE P. Plasma homocysteine levels in obstructive sleep apnea. Association with cardiovascul ar morbidity. Chest 2001; 120: 900-908.
45. JORDAN W, BERGER C, COHR S, RODENBECK A, MAYER G, NIEDMANN PD et al. CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome. J Neural Transm 2004; 111: 683-689.
46. YOKOE T, MINOGUCHI K, MATSUO H, ODA N, MINOGUCHI H, YOSHINO G et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107: 1129-1134.
47. DYUGOVSKAYA L, LAVIE P, LAVIE L. Increased adhesion molecule expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934-939.
48. SILVESTRINI M, RIZZATO B, PLACIDI F, BARUFFALDI R, BIANCONI A, DIOMEDI M et al. Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke 2002; 33: 1782-1785.
49. LECHAT P, MAS J, LASCAULT G, LORON P, THEARD M, KLINZAC M et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318: 1148-1152.
50. SHANOUDY H, SOLIMAN A, RAGGI P, LIU J, RUSSELL D, JARMUKLI N. Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest 1998; 113: 91-96.
51. BEELKE M, ANGELI S, DEL SETTE M, DE CARLI F, CANOVARO P, NOBILI L et al. Obstructive sleep apnea can be provocative for right-to-left shunting through a patent foramen ovale. Sleep 2002; 25: 856-862.
52. BEELKE M, ANGELI S, DEL SETTE M, GANDOLFO C, CABANO ME, CANOVARO P et al. Prevalence of patent foramen ovale in subjects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Med 2003; 4: 219-223.
53. WESSENDORF T, WANG Y, THILMANN A, SORGENFREI U, KONIETZKO N, TESCHLER H. Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke. Eur Respir J 2001; 18: 623-629.
54. SANDBERG O, FRANKLIN KA, BUCHT G, ERIKSSON F, GUSTAFSON Y. Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur Resp J 2001; 18: 630-634.
55. MARTÍNEZ-GARCÍA MA, GALIANO- BLANCART R, ROMÁN-SÁNCHEZ P, SOLER-CATALUNA JJ, CABERO-SALT, SALCEDO-MAIQUES E. Continuous Positive Airway Pressure Treatment in Sleep Apnea Prevents New Vascular Events After Ischemic Stroke. Chest 2005; 128: 2123-2129.
56. PARRA O. Sleep-disordered breathing and stroke: is there a rationale for treatment? Eur Respir J 2001; 18: 619-622.